| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $751K | — | -38.8% |
| Cost of Revenue | $265K | — | -19.8% |
| Gross Profit | $486K | — | -45.8% |
| R&D Expense | $50K | — | +32.5% |
| SG&A Expense | $626K | — | +44.3% |
| Operating Income | -$230K | — | -153.9% |
| Net Income | -$230K | — | -153.9% |
| EPS (Basic) | -$0.02 | — | -300.0% |
| EPS (Diluted) | -$0.02 | — | -300.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $1.1M | +73.0% | +11.3% |
| Accounts Receivable | $78K | -80.4% | -16.2% |
| Inventory | $874K | +160.0% | +305.4% |
| Current Assets | $2.2M | +40.8% | +63.9% |
| Total Assets | $2.3M | +36.5% | +67.0% |
| Total Liabilities | $646K | +180.9% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$552K | — | -268.2% |
| Investing Cash Flow | $0 | — | +100.0% |
| Financing Cash Flow | $1.0M | — | +1433.2% |
| +385.8% |
| Stockholders' Equity | $1.7M | +14.0% | +33.5% |